Enes Erul
Impact in
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 8
- Inflammatory Biomarkers in Disease Prognosis 4
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 2
- Co-authors
- Deniz Can Guven (17 shared papers)Taha Koray Şahin (14 shared papers)Sercan Aksoy (13 shared papers)Saadettin Kılıçkap (6 shared papers)Alessandro Rizzo (2 shared papers)Suayip Yalcın (6 shared papers)Thilo Gambichler (1 shared paper)Angela Dalia Ricci (2 shared papers)
- Journals
- Vaccines (4 papers)Critical Reviews in Oncology/Hematology (2 papers)Supportive Care in Cancer (2 papers)Future Oncology (2 papers)European Archives of Oto-Rhino-Laryngology (2 papers)
- Partner nations
- TürkiyeUnited StatesItaly
In The Last Decade
Enes Erul
35 papers receiving 764 citations
Peers
Comparison fields: 5 of 77
- Oncology 270
- Virology 41
- Pulmonary and Respiratory Medicine 154
- Cancer Research 58
- Health 29
Countries citing papers authored by Enes Erul
This map shows the geographic impact of Enes Erul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enes Erul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enes Erul more than expected).
Fields of papers citing papers by Enes Erul
This network shows the impact of papers produced by Enes Erul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enes Erul. The network helps show where Enes Erul may publish in the future.
Co-authors
The 25 scholars most cited alongside Enes Erul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 166 | |
| 2 | 2022 | 148 | |
| 3 | 2023 | 118 | |
| 4 | 2022 | 44 | |
| 5 | 2024 | 36 | |
| 6 | 2022 | 30 | |
| 7 | 2022 | 25 | |
| 8 | 2022 | 23 | |
| 9 | 2023 | 21 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 18 | |
| 12 | 2023 | 17 | |
| 13 | 2022 | 11 | |
| 14 | 2025 | 10 | |
| 15 | 2025 | 8 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 6 |
About Enes Erul
Enes Erul is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 39 papers that have together received 769 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Advanced Breast Cancer Therapies (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Breast Cancer Treatment Studies (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Oncology (270 citations), Virology (41 citations), Pulmonary and Respiratory Medicine (154 citations), Cancer Research (58 citations) and Health (29 citations). Enes Erul has collaborated with scholars based in Türkiye, United States and Italy. Frequent co-authors include Deniz Can Guven, Taha Koray Şahin, Sercan Aksoy, Saadettin Kılıçkap, Alessandro Rizzo, Suayip Yalcın, Thilo Gambichler, Angela Dalia Ricci, Baran Akagündüz and Raffaele De Luca. Their work appears in journals such as Vaccines, Critical Reviews in Oncology/Hematology, Supportive Care in Cancer, Future Oncology and European Archives of Oto-Rhino-Laryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.